
    
      -  Participants were treated until progressive disease, unacceptable toxicity, death, or
           participant's refusal of further study treatment. All participants were followed until
           death or the study cut-off date, whichever came first.

        -  Study cut-off was 1 month after the last participant last treatment.

        -  Participants alive at the cut-off date were not followed for overall survival.
    
  